Abstract

Abstract Background In October 2020, a research consortium by four HIV and infectious diseases units of general acute public hospitals of Buenos Aires city began an implementation study aimed to analyze obstacles and facilitators on telemedicine (TM) use in the care of people living with HIV(PLHIV). TM visits were conducted through phone or videocalls Methods This research aims to analyze shifts in patient´s perception on factors that prevent and promote the utilization of telemedicine after 6 months of implementation of this strategy. We prospectively collected qualitative data through an electronic semi-structured survey delivered at and 6 months after the first teleconsultation. Surveys were anonymous and self-administered. Data was stored in Redcap® platform. These tools collected data on barriers and benefits of this strategy Results Between October 2020 and October 2022, 45% (1871) of total enrollees (4118) answered baseline survey. Second tool was completed by 24.5% (1019) of participants. 662 participants answered both surveys. 3% (20) and 5.7% (20) in the baseline and follow-up surveys respectively, reported troubles with technological devices. This perceived barrier increased in 2.7% and this difference was statistically significant (p=0.01). Avoiding exposures to COVID-19 and other nosocomial viruses was perceived as a benefit by 65% (1216) of patients at baseline measurement. This proportion was reduced to 57% (580) at second survey. The proportion of patients that reported avoiding commuting time as a benefit increased from 44% (823) to 52% (530) between both measurements. Conclusion Beyond resource-limited contexts, these preliminary results illustrate a straightforward implementation of telemedicine. During COVID-19 pandemic, main benefits perceived by patients might be related to avoiding exposures to this and other viruses. After the COVID-19 sanitary situation was normalized, a higher percentage of patients reported that avoiding travel time to the hospital would be one of the main benefits of this strategy. Disclosures All Authors: No reported disclosures

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call